Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizPatent on Liquid Phase Hydrogenation of Alkynes
By Lawrence B. Ebert, Esq.
The patent in question US 7,408,091, is based on a continuation of the already-existing U.S. Pat. No. 7,045,670. Claim 1 recites:
A process for selective hydrogenation, comprising: preparing a reactant stream comprising an alkyne absorbed in a liquid absorbent; contacting the reactant stream with a selective hydrogenation catalyst in the presence of a gas stream comprising hydrogen and greater than 2000 ppm carbon monoxide, at hydrogenation conditions to provide a product stream; wherein the catalyst comprises a Group VIII metal; separating the absorbent from the product stream to recover a product.
The chemistry in question occurs in a relatively expensive "non-hydrocarbon" liquid:
The non-hydrocarbon liquid absorbent may comprise, without limitation: n-methyl-2-pyrrolidone (NMP), acetone, tetrahydrofuran (THF), dimethylsulfoxide (DMSO), monomethylamine (MMA), and/or combinations thereof, and is preferably NMP. The hydrogenation may preferably be effected by passing the absorbed acetylene and/or acetylenic compounds into the inlet of a fixed bed reactor, or a series of reactors, containing the catalyst, while co-currently passing a stream of gas containing at least hydrogen into the reactor at an inlet location.
The source of acetylene and/or acetylenic compounds and/or hydrogen and/or carbon monoxide may preferably be pyrolysis, thermal cracking, steam cracking, partial oxidation, or other like process, wherein hydrocarbons or hydrocarbon-containing streams are thermally and/or chemically modified to produce increased quantities of unsaturated components, and the acetylene and/or acetylenic compounds may comprise, but are not limited to: acetylene, allene, vinyl acetylene, methyl acetylene, ethyl acetylene, 1-butyne, 2-butyne, and 1,3-butadiyne.
Revolutionary?
Full post as published by IPBiz on August 23, 2008 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment
Qualcomm Settles Patent Suit for $891 Million
The Princeton Review
$2.6 million settlement reached in patent infringement case.

US Patent 7316789 - Liquid crystal polymer matrix for carbon nanotube alignment
US Patent 7425582 - Stable dispersion using surface modified nanoparticles
US Patent 7316967 - Flow method for nanocrystal fabrication
US Patent 7326368 - Toxicity reduction of liquid metal using nanoparticles
US Patent 7360851 - Feedback adjustment for nanoimprint lithography density control
US Patent 7378701 - Phase change CNT memory








